理邦仪器收盘上涨2.01%，滚动市盈率35.88倍，总市值67.70亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of the company, Ribang Instrument, within the medical device industry, noting its recent stock price increase and market capitalization [1][2] - As of April 30, Ribang Instrument's closing price was 11.68 yuan, reflecting a 2.01% increase, with a rolling PE ratio of 35.88, marking a new low in 19 days, and a total market value of 6.77 billion yuan [1] - The average PE ratio for the medical device industry is 48.11, with a median of 35.88, positioning Ribang Instrument at the 75th rank within the industry [1][2] Group 2 - For the first quarter of 2025, Ribang Instrument reported an operating income of 420 million yuan, representing a year-on-year decrease of 5.25%, while net profit reached 65.09 million yuan, showing a significant increase of 68.98% [2] - The company's gross profit margin stands at 58.34%, indicating a strong profitability despite the decline in revenue [2] - As of the first quarter of 2025, two institutions held shares in Ribang Instrument, with a total holding of 48.78 million shares valued at 591 million yuan [1]